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Primary liver sarcomas represent a rare group of neoplasias, with angiosarcoma being the most common histological type. Primi-
tive neuroectodermal tumor (PNET) represents a high malignant neoplasia that usually aﬀects the central nervous system and soft
tissues.An18-year-oldmalepatientwasadmittedwithclinicalcomplainsofpainintherightupperabdominalquadrant.Theclin-
ical evaluation revealed a solid mass in the right hepatic lobe. On the gross examination of the resected liver specimen, the right
lobe of the liver was replaced by a yellow-red solid mass measuring 21cm in its largest dimension. On the histopathology, a tu-
mor composed of small round blue cells with little cytoplasm and round nuclei was identiﬁed. The lesion revealed positive immu-
noexpression for vimentin and CD99 and negative immunostaining for desmin, CD45, cytokeratin, and neuroblastoma protein,
suggesting,then,thediagnosisofPNET.Althoughitisanunusualtumor,itshouldbeconsideredinthediﬀerentialdiagnosisofliv-
er masses, especially in young patients.
1.Introduction
Liver neoplastic lesions include many diﬀerent histological
typesofprimarybenignandmalignantmassesandhighrates
ofmetastaticprocesses.Primarytumorscanbesolidorcystic
and can arise from hepatocyte, bile duct epithelium, neu-
roendocrinecells,mesenchymalcells,and,rarely,fromheter-
otopic tissues [1, 2]. Hepatoblastoma and mesenchymal ha-
martoma are usually found in the pediatric population. He-
patocellular carcinoma represent the single most common
histologic type of malignant epithelial tumors of the liver
(about 85–90%), being frequently associated to cirrhosis and
chronic viral hepatitis. Primary hepatic sarcomas are exceed-
ingly unusual, accounting for only 1% to 2% of all malignant
tumors arising in the liver, with angiosarcoma and undiﬀer-
entiated sarcoma being the most common histologic types
[1, 2].
PNETrepresentsafamilyoftumorswhichshowsvarying
d e g r e e so fn e u r o n a ld i ﬀerentiation with an Ewing’s sarcoma
gene rearrangement, most often as a consequence of a t (11;
22) (q24; q12) chromosomal translocation. PNET is a high-
lymalignant neoplasm most commonlyinvolving the central
nervous and skeletal system, and it is composed of small,
round,uniformcells.Becauseoftheundiﬀerentiatedappear-
ance of the tumor cells, it looks as if the original cell might be
an undiﬀerentiated mesenchymal cell [3–5]. Herein, the au-
thorsreportacaseofPNETarisingintheliverandreviewthe
morphologic and immunohistochemical ﬁndings of this tu-
mor in a rare topography.
2.CaseReport
An 18-year-old male African descent patient was admitted
complaining of pain in the right upper quadrant of the ab-
dominal region for the last 3 months. The physical exam-
ination revealed a ﬁrm, solid mass with an irregular lower
border and mild tenderness in the liver topography. Abdom-
inal ultrasonography and computed tomography (CT) scans
showed a solid mass in the right hepatic lobe, measuring
21cm in its largest diameter, with possible colon and right
kidney invasion, and vena cava compression (Figure 1). Pre-
operative right hepatic artery embolization was performed.2 Case Reports in Medicine
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Figure 1: Preoperative CT scan showing a large, solid mass in the liver.
Figure 2: PNET arising in the liver: diﬀuse sheet of uniform small
round cells in a lobulated growth pattern, HE, 200x.
Figure 3: PNET arising in the liver: positive immunoexpression for
vimentin, streptavidin-biotin, 200x.
In follow-up CT, areas of partial necrosis and no tumor size
regression were found. The patient underwent exploratory
laparotomy. The right lobe of the liver was partially replaced
by a yellow-purple-red solid tumor, which was in continuity
with the right kidney and hepatic colon ﬂexure. There were
no signs of peritoneal disease and no evidence of metastasis
in liver segments 1 to 3. A right extended hepatectomy with
en bloc resection of the right kidney, gallbladder, and partial
Figure 4: PNET arising in the liver: the tumor cells show
immunoreactivity for CD99, streptavidin-biotin, 200x.
colectomy (hepatic colon ﬂexure) with primary anastomosis
was performed.
The surgical specimen consisted of a portion of the liv-
er, of the gallbladder, a segment of the colon, and of the
right kidney, previously ﬁxed in formalin, measuring 30cm
× 25cm × 13.5cm, and weighing 4313g. On cut surface, the
hepatic parenchyma was replaced by a yellowish-gray, multi-
lobulated, soft tumor, with yellow central areas, that mea-
sured 21cm in its largest diameter. The lesion was adhered to
the colon and kidney, but without clear signs of invasion. On
hematoxylin-eosin staining, a neoplastic process composed
ofsheetsorlobulesofsmallroundcells,withlittlecytoplasm,
and darkly staining, round or oval nuclei, was identiﬁed
(Figure 2). The lesion also showed areas of necrosis, high
mitotic index, and rare rosettes. The immunohistochemical
study of lesion revealed positive expression for vimentin
(Vim 3B4—Figure 3) and CD99 (12E7—Figure 4), and
negative immunostaining for desmin (D33), cytokeratin
(AE1/AE3), and neuroblastoma protein (NB84). The liver
parenchyma adjacent to the tumor had a normal histologic
appearance. The morphology of the hepatic lesion associated
with the ﬁndings of the immunohistochemical study was
consistent with PNET. One month after surgery, venousCase Reports in Medicine 3
thrombosis extending from the iliac vessels to the right atri-
um and multiple metastatic implants in the lungs were iden-
tiﬁed in thoracic CT. The patient had a sudden death due to
massive pulmonary thromboembolism. At this time, it was
not possible to perform genetic studies to establish the line-
age of the neoplasm.
3. Discussion
PNETsaresmallroundcelltumorsthatbelongtotheEwing’s
sarcoma family of tumors. These tumors are divided in
two main categories: central (derived from the neural tube)
and peripheral (outside the central nervous system) [6–10].
PNETs were ﬁrst described by Stout in 1918 [7, 10, 11]
and represent less than 1% of all sarcomas [7, 12]. These
sarcomas predominantly aﬀect bones and deep soft tissue
and rarely aﬀect visceral organs. PNET can be found in
the thorax (44%), abdomen and pelvis (44%), extremities
(20%), and 6% in the head and neck areas [9, 12]. Visceral
primary commitment has been described with increasing
frequency in the pancreas, vagina, stomach, small bowel,
ovaries, esophagus, and kidney [5–10].
The gross appearance of the tumor varies. In general, it
is multilobulated, soft, and friable; it rarely exceeds 10cm
in its largest dimension. Its cut surface has a gray-yellow or
gray-tan appearance, often with large areas of necrosis, cyst
formation, or hemorrhage. Despite the extensive necrosis,
calciﬁcation is rare [4, 5, 13].
At microscopy, the typical PNET shows a predomi-
nantly lobular growth pattern, with little or no stroma.
It is composed of poorly diﬀerentiated small round cells
containing darkly staining, round or oval nuclei. The pale
eosinophilic cytoplasm is indistinct except in areas where the
cellsaremorematureandtheelongatedhair-likecytoplasmic
extensions coalesce to form rosettes. Most of the rosettes
are similar to those seen in neuroblastomas and contain a
central solid core of neuroﬁbrillary material. Rarely do the
rosettes contain a central lumen or vesicle. Some tumors are
composedofcordsortrabeculaeofsmallroundcellsthatcan
be mistaken by a carcinoid tumor or a small-cell undiﬀeren-
tiated carcinoma. The presence of areas of necrosis is a usual
ﬁnding. There are uncommon tumors with glial, ependymal,
cartilaginous, or epithelial diﬀerentiation. Some areas can
resemble a ﬁbrosarcoma or a malignant schwannoma [4,
5, 13, 14]. The ultrastructural features include the presence
of elongated cell processes that interdigitate with each
other and contain small dense-core granules (neurosecretory
granules) that measure 50–100nm and occasionally contain
microtubules [14, 15]. On immunostains, many PNETs are
usually positive for CD99, neuron-speciﬁc enolase, Leu-7,
S-100, and synaptophysin, and negative for desmin and
Myogenin/MyoD1. Some cases are positive for cytokeratin
[3–5, 14–16]. PNET characteristically exhibits a neural phe-
notype, expressing the MIC2-protein (CD99), and display
thet (11;22)(q24;q12)chromosomaltranslocationinabout
85%–95% of the cases [3, 7, 8, 17–22].
The diﬀerential diagnosis includes neuroblastoma (pos-
itive for NB84), desmoplastic small round cell tumor, mes-
enchymal chondrosarcoma, alveolar rhabdomyosarcoma,
non-Hodgkin’s lymphoma, metastatic pulmonary small-cell
carcinoma, cutaneous neuroendocrine carcinoma, small-cell
osteosarcoma, and poorly diﬀerentiated synovial sarcoma
[3–5, 13, 18–20, 22].
T r e a t m e n tw i t hs u r g e r ya l o n ef o re x t r a s k e l e t a lP N E T
is considered insuﬃcient, and multimodal treatment with
chemotherapy and radiotherapy is frequently performed.
Despite the multimodal treatment, most patients show a
rapid dissemination of the disease. Key prognostic factors
that adversely inﬂuence the outcome are the presence of me-
tastatic disease at the time of the initial diagnosis, large tu-
morsize,extensivenecrosis,centralaxistumors,andpoorre-
sponsetoinitialchemotherapy.Patientswithtype1EWS/FLI
fusion transcripts appear to have longer disease-free survival
than those with other fusion transcript types [3, 5, 6, 19–21].
4. Conclusion
P N E T sa r eu s u a l l ya g g r e s s i v es m a l lb l u ec e l lt u m o r sa r i s i n g
in the central nervous or skeletal system. To the best of our
knowledge, this is the third case report of this tumor arising
in liver parenchyma. Although it is an unusual liver tumor
associated with poor prognosis, PNET should be considered
in the diﬀerential diagnosis of liver masses, especially in
young patients.
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